Fachliteratur Gastroenterologie: Neoplasien Pankreas

Fr | De

Feedback | Impressum | Sitemap

Keine Artikel ausgewählt!

Warenkorb

Sie sind hier: Fachliteratursuche » Pankreas » Neoplasie

30. Juli 2026

Abklärungen / Diagnostik

Therapien

Guidelines

Fortbildung

News / Journalscreening

Schrift:

Seite 1 von 3052


	Artikel 1 - 20 / 61028

	Fatty acids metabolic reprogramming and tumor microenvironment in pancreatic cancer: targeting pathways. Clin Exp Med Ehab B, Saleh E. PMID: 42525264 [PubMed - indexed for MEDLINE]
	Definition of Conversion Therapy and Neoadjuvant Therapy for Hepatocellular Carcinoma: A Consensus Guideline from the Japan Liver Cancer Association. Liver Cancer Ichida A, Tateishi R, Hatano E, Taketomi A, Tanabe M, Nouso K, Minami Y, Murakami T, Shimada M, Hasegawa K. PMID: 42524660 [PubMed - as supplied by publisher]
	Systemic therapy for gastroenteropancreatic neuroendocrine neoplasms: current landscape and future directions. Ther Adv Med Oncol So E, Morizane C, Okusaka T. PMID: 42524036 [PubMed]
	Cancer outcomes and biological mechanisms among patients with type 2 diabetes mellitus using glucagon-like peptide-1 receptor agonists: a systematic review and meta-analysis. Front Oncol Eze ED, Ntakirutimana L, Terkimbi SD, Walle M, Umar AH, Wondimu DH, Olubiyi MV, Okeke OC, Onaadepo O, Abdulazeez J, Ikwuka DC, Ani EJ, Alagbonsi AI. PMID: 42523690 [PubMed]
	Metabolic comorbidities affect the survival of hepatitis B virus-related hepatocellular carcinoma in Chinese patients: a retrospective cohort study with propensity score matching. Front Oncol Zhou Z, Zheng X, Lin Z, Chen X, Xie M. PMID: 42523603 [PubMed]
	Red and processed meat consumption and the risk of pancreatic cancer: a systematic review and dose-response meta-analysis. Front Nutr Lu Y, Gu M, Zhao Y, Ma L, Wei Y, Liu Z, Wu Y, Fu X, Liang J, Yang L, Su Y, Chen T, Zhang D, Hu F, Hu D, Zhang M. PMID: 42523589 [PubMed - in process]
	Prognostic and Predictive Values of Transcriptomic Signatures in Metastatic Pancreatic Cancer: A Biomarker Analysis of Three French Multicenter Prospective Randomized Controlled Phase 2 Trials (Prodige35, Prodige37 and AFUGEM). Cancer Lett Zhao S, Nicolle R, Taieb J, Dahan L, Abdallah R, Bouché O, Desrame J, Phelip JM, Evesque L, Akouz FK, de Mestier L, Trouilloud I, Malka D, Shen B, Cros J, Laurent-Puig P, Bachet JB. PMID: 42521075 [PubMed - as supplied by publisher]
	Discovery of a prognostic two-lncRNA panel correlated with immune-associated transcripts for forecasting overall survival in pancreatic cancer. Immunobiology Eftekhari H, Safarzadeh A, Babakhanzadeh E, Ghafouri-Fard S. PMID: 42520353 [PubMed - as supplied by publisher]
	Correction: Impact of Hypertrophy-Oriented Resistance Training on Muscle Mass and Quality of Life in Patients with Unresectable Pancreatic Cancer (HY-PANC): Study Protocol for a Randomized Controlled Trial. Curr Protoc Braceras Arias P, Burgos Postigo S, B Alejo L. PMID: 42519871 [PubMed - in process]
	Research advances on tumor-associated macrophages in pancreatic cancer. Biochem Biophys Rep Miao JY, Zhang LQ, He Y, Wang W. PMID: 42519576 [PubMed]
	Dual-Modality SPECT and Viscosity-Responsive AIE Fluorescence Probe for Pancreatic Cancer Diagnosis and Intraoperative Guidance. ACS Omega Zhang K, Chen Q, Huang Q, Qi X, Qin Y, Wang D, Zhu R, Wang G, Ma X. PMID: 42518470 [PubMed]
	Berberine-induced ferroptosis as a novel anti-cancer strategy: Molecular, epigenetic and translational perspectives. EXCLI J Agrawal N, Gupta G, Pandey SN, Rekha A, Vijayan MP, Chellappan DK, Raj Paudal K, Singh SK, Dua K. PMID: 42517086 [PubMed]
	Molecular Imaging in Pancreatic Cancer: Current Applications and Future Perspectives. Pharmaceuticals (Basel) Liu Y, Lan K, Sun Z, Huang W. PMID: 42515759 [PubMed]
	Study on Synergistic Treatment of Pancreatic Cancer by Multiple Small Interfering Ribonucleic Acid Lipid Nanoparticles of Disk Domain Receptor 1, Transforming Growth Factor Î²1, Tumor-Associated Calcium Signal Transduction Protein 2, and Polyligand Proteoglycan 1. Pharmaceutics Wang R, Zeng Y, Zeng Z, Xie T. PMID: 42514856 [PubMed]
	Estimation of Resting Energy Expenditure in Patients Undergoing Total or Partial Pancreatectomy for Pancreatic Tumors. Nutrients Papanastasiou P, Bouloubasi Z, Karayiannis D, Georgolopoulou O, Chasiotis D, Goulis I, Dimitriou M. PMID: 42514285 [PubMed - indexed for MEDLINE]
	Precision Therapeutics in Pancreatic Cancer: Emerging Targeted, Immune, and Antibody-Drug Conjugate Strategies Exemplified by Adagrasib, Dostarlimab, and Trastuzumab Deruxtecan. J Clin Med Kawczak P, Kawczak K, B. PMID: 42513436 [PubMed]
	Endoscopic Ultrasound-Guided Radiofrequency Ablation (EUS-RFA): Are We Getting Evidence-Based Results? A Systematic Review According to the Levels of Evidence. Medicina (Kaunas) Lisotti A, Masciangelo G, Tacelli M, Crinò SF, Pham KD, Khoury T, Fusaroli P, Napoléon B. PMID: 42512924 [PubMed - indexed for MEDLINE]
	The Global Immune-Nutrition-Inflammation Index Is Associated with Survival Outcomes and Enhances Prognostic Discrimination in Metastatic Pancreatic Cancer. Medicina (Kaunas) Yüceer K, Bozkurt O, Inanç M, Ozkan M. PMID: 42512821 [PubMed - indexed for MEDLINE]
	Cancer-Associated Fibroblast Heterogeneity and Extracellular Matrix Remodeling as Orchestrators of Drug Resistance in Upper Gastrointestinal Cancers: Insights from Spatial Multi-Omics and Therapeutic Implications. Cancers (Basel) Mirzabeigi Y, Youssef J, Gonzalez J, Martinez T, Avellan R, Wong A, Perez M, Carvajal LL, Abou-Kheir W, Bahmad HF. PMID: 42512419 [PubMed]
	Vitamin D Status and Gastroenteropancreatic Neuroendocrine Neoplasms: Biological Rationale, Clinical Associations and Limitations of Current Evidence. Cancers (Basel) Basiaga B, Rosiek V, Kos-Kud. PMID: 42512408 [PubMed]

Artikel 1 - 20 / 61028

Seite 1 von 3052



		Zeitfenster

Ironmedline

Das Fachportal für Eisenmangel >>

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Datenschutzerklärung / Privacy Policy \| Werbung